• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5071034)   Today's Articles (71)
For: Leclercq M, Andrillon A, Maalouf G, Sève P, Bielefeld P, Gueudry J, Sené T, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, El Chamieh C, Cacoub P, Bodaghi B, Biard L, Saadoun D. Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network. Ophthalmology 2021;129:520-529. [PMID: 34793830 DOI: 10.1016/j.ophtha.2021.11.013] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 11/01/2021] [Accepted: 11/08/2021] [Indexed: 12/16/2022]  Open
Number Cited by Other Article(s)
1
Leclercq M, Jacquot R, Charbonnier C, Desbois AC, Maalouf G, Touhami S, Ghembaza A, Domont F, Leroux G, Sales de Gauzy T, Toutée A, Girszyn N, Goupillou P, Muraine M, Fardeau C, Benhamou Y, Kodjikian L, Cacoub P, Sève P, Bodaghi B, Saadoun D, Gueudry J. Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysis. Ophthalmology 2025:S0161-6420(25)00313-6. [PMID: 40398691 DOI: 10.1016/j.ophtha.2025.05.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2024] [Revised: 05/05/2025] [Accepted: 05/13/2025] [Indexed: 05/23/2025]  Open
2
Goupillou P, Leclercq M, Muraine M, Girszyn N, Gueudry J. Prognostic Factors of Treatment Failure with First-Line Corticosteroid-Sparing Agents in Patients with Birdshot Chorioretinopathy: A Retrospective Study. Ocul Immunol Inflamm 2025:1-5. [PMID: 40262577 DOI: 10.1080/09273948.2025.2491570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2025] [Revised: 04/02/2025] [Accepted: 04/05/2025] [Indexed: 04/24/2025]
3
Sener H, Gulmez Sevim D, Temizyurek O, Uludag MT, Ozer F, Evereklioglu C, Beyza Akdeniz Z, Gunay Sener AB, Horozoglu F. Outcomes in non-infectious uveitis patients treated with adalimumab in a tertiary eye care center. J Fr Ophtalmol 2025;48:104457. [PMID: 40056769 DOI: 10.1016/j.jfo.2025.104457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2024] [Revised: 07/27/2024] [Accepted: 10/08/2024] [Indexed: 03/10/2025]
4
Shunyakova J, Reynolds M, Taylor A, Sieck EG, Walsh JT, Hassman LM. Case Report: ROSAH syndrome presents diagnostic and therapeutic challenges. FRONTIERS IN OPHTHALMOLOGY 2025;5:1535805. [PMID: 40201710 PMCID: PMC11975653 DOI: 10.3389/fopht.2025.1535805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/27/2024] [Accepted: 02/13/2025] [Indexed: 04/10/2025]
5
Tan K, Liu P, Wu Z, Long X, Yu Y, Jiang P, Peng Q. Molecular insights into ulcerative colitis and orbital inflammation. Sci Rep 2025;15:7130. [PMID: 40021664 PMCID: PMC11871363 DOI: 10.1038/s41598-025-89344-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2024] [Accepted: 02/04/2025] [Indexed: 03/03/2025]  Open
6
Putera I, Thiadens AAHJ, Larasmanah ASN, La Distia Nora R, Dik WA, van Hagen PM, Rombach SM, Ten Berge JCEM. Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual Outcomes. Eye (Lond) 2025;39:593-601. [PMID: 39774294 PMCID: PMC11794657 DOI: 10.1038/s41433-024-03577-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2024] [Revised: 12/05/2024] [Accepted: 12/19/2024] [Indexed: 01/11/2025]  Open
7
Pu Y, Liang J, Wang Y, Zhang W, Zhou C, Shao J, Hu J, Chen M, Shi Y, Mao Y, Chen Z. Integrated analysis of genetic, proteinic, and metabolomic alterations in Behcet's disease. Sci Rep 2025;15:2746. [PMID: 39838177 PMCID: PMC11751112 DOI: 10.1038/s41598-025-87130-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2024] [Accepted: 01/16/2025] [Indexed: 01/23/2025]  Open
8
Barresi C, Baldo F, Menean M, Marino A, Costi S, Chighizola CB, Caporali RF, Miserocchi E. Juvenile idiopathic arthritis and associated uveitis: A review of pathogenesis, diagnosis, and management. Saudi J Ophthalmol 2025;39:31-40. [PMID: 40182964 PMCID: PMC11964343 DOI: 10.4103/sjopt.sjopt_153_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2024] [Accepted: 10/20/2024] [Indexed: 04/05/2025]  Open
9
Mori T, Nagaraj NR, Surico PL, Zhou W, Parmar UPS, D’Esposito F, Gagliano C, Musa M, Zeppieri M. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review. Open Life Sci 2024;19:20221023. [PMID: 39759107 PMCID: PMC11699559 DOI: 10.1515/biol-2022-1023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Revised: 10/29/2024] [Accepted: 11/25/2024] [Indexed: 01/07/2025]  Open
10
Yu X, Duan R, Jiang L, Wang T, Li Z, Zhang B, Su W, Lin Y. Interleukin-6 in non-infectious uveitis: Biology, experimentalevidence and treatment strategies. Biochem Pharmacol 2024;230:116605. [PMID: 39491564 DOI: 10.1016/j.bcp.2024.116605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2024] [Revised: 10/10/2024] [Accepted: 10/31/2024] [Indexed: 11/05/2024]
11
Zur Bonsen LS, Schulze D, Künzel SE, Rübsam A, Pleyer U, Pohlmann D. Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis. J Ophthalmic Inflamm Infect 2024;14:61. [PMID: 39570440 PMCID: PMC11582289 DOI: 10.1186/s12348-024-00443-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2024] [Accepted: 11/14/2024] [Indexed: 11/22/2024]  Open
12
Ali N, Sims J, Niederer R. Uveitic Macular Edema: Clinical Outcomes in Real-World Practice. Ocul Immunol Inflamm 2024;32:2105-2113. [PMID: 38547157 DOI: 10.1080/09273948.2024.2328769] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Revised: 03/01/2024] [Accepted: 03/05/2024] [Indexed: 10/26/2024]
13
Gil W, Kodjikian L, Andre M, Kaur I, Durel CA, Hot A, Fauter M, Chaigne B, Smets P, Samson M, Seve P. Uveitis in Giant Cell Arteritis: A Retrospective Study of Seven Observational Cases and Literature Review. Ocul Immunol Inflamm 2024;32:1844-1851. [PMID: 37815855 DOI: 10.1080/09273948.2023.2264383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Revised: 09/23/2023] [Accepted: 09/23/2023] [Indexed: 10/11/2023]
14
Fardeau C, Breville G, Jeannerot AL, Herrmann F, Touati M, Bonnin S, Sales de Gauzy T, Sadegh A, Toumi A, Baglivo E, Cohen D, Karmochkine M, Bodaghi B, Seebach JD, Le Hoang P. CYSTOID MACULAR EDEMA IN BIRDSHOT RETINOCHOROÏDITIS: Long-Term Treatment Study in 142 Patients. Retina 2024;44:1814-1822. [PMID: 39287545 DOI: 10.1097/iae.0000000000004177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2024]
15
Abramowicz S, Kamgang Semeu P, Nubourgh I, Postelmans L, Willermain F. Tocilizumab for cystoid macular edema secondary to retinitis pigmentosa. J Ophthalmic Inflamm Infect 2024;14:47. [PMID: 39349884 PMCID: PMC11442707 DOI: 10.1186/s12348-024-00430-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2024] [Accepted: 09/09/2024] [Indexed: 10/04/2024]  Open
16
Jimenez YP, Neri P, Al Ali S, Aljneibi S, Aldhanhani A, Al Masri K, Agarwal A, Pichi F. Corticosteroids for the Management of Uveitic Macular Edema: A Comprehensive Review. Ocul Immunol Inflamm 2024:1-14. [PMID: 39235342 DOI: 10.1080/09273948.2024.2395289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Revised: 08/14/2024] [Accepted: 08/16/2024] [Indexed: 09/06/2024]
17
Kudsi M, Al-Darwish L, Khalayli N, Abouharb D, Abouharb L, Almajzoub R, Deeb H. Characterizing autoimmune uveitis to systemic diseases: a retrospective study from a Syrian tertiary reference center. Ann Med Surg (Lond) 2024;86:3929-3935. [PMID: 38989239 PMCID: PMC11230743 DOI: 10.1097/ms9.0000000000002054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Accepted: 03/30/2024] [Indexed: 07/12/2024]  Open
18
Guan Y, Li F, Li N, Yang P. Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances. J Neuroinflammation 2024;21:133. [PMID: 38778397 PMCID: PMC11112928 DOI: 10.1186/s12974-024-03123-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Accepted: 05/04/2024] [Indexed: 05/25/2024]  Open
19
Xenitidis T, Henes JC. [An update on Behçet's syndrome]. Laryngorhinootologie 2024;103:352-357. [PMID: 38330997 DOI: 10.1055/a-2249-2116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2024]
20
Samalia PD, Lim LL, Niederer RL. Insights into the diagnosis and management of sarcoid uveitis: A review. Clin Exp Ophthalmol 2024;52:294-316. [PMID: 38385625 DOI: 10.1111/ceo.14366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 01/08/2024] [Accepted: 01/19/2024] [Indexed: 02/23/2024]
21
Tu Y, Guo Y, Sun H, Zhang Y, Wang Q, Xu Y, Xie L, Zhu M. Tocilizumab attenuates choroidal neovascularization by regulating macrophage polarization through the IL-6R/STAT3/VEGF pathway. Heliyon 2024;10:e27893. [PMID: 38524531 PMCID: PMC10958357 DOI: 10.1016/j.heliyon.2024.e27893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 03/07/2024] [Accepted: 03/07/2024] [Indexed: 03/26/2024]  Open
22
Esteban-Ortega M, Steiner M, Andreu-Vázquez C, Thuissard-Vasallo I, Díaz-Rato A, Muñoz-Fernández S. An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis. J Clin Med 2024;13:1402. [PMID: 38592203 PMCID: PMC10933845 DOI: 10.3390/jcm13051402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 02/22/2024] [Accepted: 02/25/2024] [Indexed: 04/10/2024]  Open
23
Sener H, Evereklioglu C, Horozoglu F, Gunay Sener AB. Efficacy and Safety of Adalimumab in Patients with Behçet Uveitis: A Systematic Review and Meta-Analysis. Ocul Immunol Inflamm 2024;32:89-97. [PMID: 36625549 DOI: 10.1080/09273948.2022.2157288] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 12/06/2022] [Indexed: 01/11/2023]
24
Ferreira LB, Williams KA, Best G, Haydinger CD, Smith JR. Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis. Clin Transl Immunology 2023;12:e1479. [PMID: 38090668 PMCID: PMC10714664 DOI: 10.1002/cti2.1479] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Revised: 09/22/2023] [Accepted: 11/21/2023] [Indexed: 06/30/2024]  Open
25
Zhong Z, Su G, Yang P. Risk factors, clinical features and treatment of Behçet's disease uveitis. Prog Retin Eye Res 2023;97:101216. [PMID: 37734442 DOI: 10.1016/j.preteyeres.2023.101216] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 09/09/2023] [Accepted: 09/15/2023] [Indexed: 09/23/2023]
26
Joubert M, Desbois AC, Domont F, Ghembaza A, Lejoncour A, Mirouse A, Maalouf G, Leclercq M, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Behçet's disease uveitis. Rev Med Interne 2023;44:546-554. [PMID: 37414674 DOI: 10.1016/j.revmed.2023.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 06/06/2023] [Indexed: 07/08/2023]
27
Xenitidis T, Henes JC. [An update on Behçet's syndrome]. Dtsch Med Wochenschr 2023;148:1129-1134. [PMID: 37611579 DOI: 10.1055/a-1958-2338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/25/2023]
28
Xiao R, Lei C, Zhang Y, Zhang M. Interleukin-6 in retinal diseases: From pathogenesis to therapy. Exp Eye Res 2023:109556. [PMID: 37385535 DOI: 10.1016/j.exer.2023.109556] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2023] [Revised: 06/03/2023] [Accepted: 06/25/2023] [Indexed: 07/01/2023]
29
Liu W, Bai D, Kou L. Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis. BMC Ophthalmol 2023;23:240. [PMID: 37248486 DOI: 10.1186/s12886-023-02987-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 05/23/2023] [Indexed: 05/31/2023]  Open
30
Joubert M, Desbois AC, Domont F, Ghembaza A, Le Joncour A, Mirouse A, Maalouf G, Leclercq M, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Behçet's Disease Uveitis. J Clin Med 2023;12:jcm12113648. [PMID: 37297843 DOI: 10.3390/jcm12113648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 04/26/2023] [Accepted: 05/20/2023] [Indexed: 06/12/2023]  Open
31
Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L, Sève P. Sarcoidosis-Related Uveitis: A Review. J Clin Med 2023;12:jcm12093194. [PMID: 37176633 PMCID: PMC10178951 DOI: 10.3390/jcm12093194] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/15/2023]  Open
32
Ferreira LB, Ashander LM, Appukuttan B, Ma Y, Williams KA, Best G, Smith JR. Human retinal endothelial cells express functional interleukin-6 receptor. J Ophthalmic Inflamm Infect 2023;13:21. [PMID: 37097497 PMCID: PMC10130314 DOI: 10.1186/s12348-023-00341-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 04/01/2023] [Indexed: 04/26/2023]  Open
33
Interleukin-6 and Macular Edema: A Review of Outcomes with Inhibition. Int J Mol Sci 2023;24:ijms24054676. [PMID: 36902105 PMCID: PMC10003386 DOI: 10.3390/ijms24054676] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 02/24/2023] [Accepted: 02/25/2023] [Indexed: 03/06/2023]  Open
34
Busto-Iglesias M, Rodríguez-Martínez L, Rodríguez-Fernández CA, González-López J, González-Barcia M, de Domingo B, Rodríguez-Rodríguez L, Fernández-Ferreiro A, Mondelo-García C. Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review. Pharmaceutics 2023;15:pharmaceutics15030766. [PMID: 36986627 PMCID: PMC10051556 DOI: 10.3390/pharmaceutics15030766] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Revised: 02/17/2023] [Accepted: 02/22/2023] [Indexed: 03/03/2023]  Open
35
Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review. CHILDREN 2023;10:children10030434. [PMID: 36979992 PMCID: PMC10047268 DOI: 10.3390/children10030434] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 02/17/2023] [Accepted: 02/21/2023] [Indexed: 02/25/2023]
36
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients. Semin Arthritis Rheum 2023;58:152153. [PMID: 36549244 DOI: 10.1016/j.semarthrit.2022.152153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 11/29/2022] [Accepted: 12/09/2022] [Indexed: 12/23/2022]
37
Ozguler Y, Esatoglu SN, Hatemi G. Current pharmacological solutions for Behçet's syndrome. Expert Opin Pharmacother 2023;24:221-231. [PMID: 36458741 DOI: 10.1080/14656566.2022.2155047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
38
Pépin F, Niederer RL. Re: Leclercq et al.: Anti-tumor necrosis factorα versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network. (Ophthalmology. 2021 Nov 16;S0161-6420(21)00900-3. doi: 10.1016/j.ophtha.2021.11.013. Online ahead of print. [Epub ahead of print]. Ophthalmology 2022;129:e77. [PMID: 35346510 DOI: 10.1016/j.ophtha.2022.02.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Accepted: 02/18/2022] [Indexed: 11/25/2022]  Open
39
Tsui E, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan J, Ebert CD, Kim E, Madow B, Porco TC, Acharya NR. Outcomes of uveitic macular edema in the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial. Ophthalmology 2022;129:661-667. [PMID: 35143800 DOI: 10.1016/j.ophtha.2022.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Revised: 01/31/2022] [Accepted: 02/02/2022] [Indexed: 11/29/2022]  Open
40
Shivpuri A, Turtsevich I, Solebo AL, Compeyrot-Lacassagne S. Pediatric uveitis: Role of the pediatrician. Front Pediatr 2022;10:874711. [PMID: 35979409 PMCID: PMC9376387 DOI: 10.3389/fped.2022.874711] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2022] [Accepted: 07/08/2022] [Indexed: 11/17/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA